Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Double trouble or a silver lining? A case report of two patients with NPM1-mutated donor-derived acute myeloid leukemia (AML)

Loh JBE, Walker P, Avery S, Patil S, Spencer A, Wei A, Fleming S

(2021), LEUKEMIA LYMPHOMA, 62(2), 489-91

DOI: 10.1080/10428194.2020.1832663

Evaluation of EuroFlow minimal residual disease measurement and donor chimerism monitoring following tandem auto-allogeneic transplantation for multiple myeloma

Tan JLC, Das T, Kliman D, Muirhead J, Gorniak M, Kalff A, Walker P, Spencer A

(2021), BONE MARROW TRANSPL, 56(5), 1116-25

DOI: 10.1038/s41409-020-01148-y

Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma

Mithraprabhu S, Kalff A, Gartlan KH, Savvidou I, Khong T, Ramachandran M, Cooke RE, Bowen K, Hill GR, Reynolds J, Spencer A

(2021), BRIT J HAEMATOL, 193(1), 160-70

DOI: 10.1111/bjh.17080

Long-Term Immune Function Following Splenic Artery Embolisation for Blunt Abdominal Trauma

Lukies M, Kavnoudias H, Zia A, Lee R, Bosco JJ, Joseph T, Clements W

(2021), CARDIOVASC INTER RAD, 44(1), 167-9

DOI: 10.1007/s00270-020-02627-x

Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency

Edwards ESJ, Bosco JJ, Ojaimi S, O'Hehir RE, van Zelm MC

(2021), Cell Mol Immunol, 18(3), 588-603

DOI: 10.1038/s41423-020-00520-8

Antimicrobial resistance in the Pacific Island countries and territories.

Loftus M, Stewardson A, Naidu R, Coghlan B, Jenney A, Kepas J, Lavu E, Munamua A, Peel T, Sahai V, Tekoaua R, Tudravu L, Zinihite J, Cheng A, Rafai E, Peleg A

(2020), BMJ Glob Health, 5(4), e002418

DOI: 10.1136/bmjgh-2020-002418

Prevalence of hyperglycaemia without previously recognised diabetes mellitus in the Emergency Department and subsequent management - A retrospective cross-sectional study

Epa DS, Ng E, Schneider HG, Nagalingam V, Bach LA, Sztal-Mazer S

(2020), Intern Med J, 50(11), 1397-1403

DOI: 10.1111/imj.14720

Arterio-VENouS Intra Subject agreement for blood gases within intensive care: The AVENSIS study

Nanjayya VB, McCracken P, Vallance S, Board J, Kelly PJ, Schneider HG, Pilcher D, Garner DJ

(2020), Journal of the Intensive Care Society, 21(1), 64-71

DOI: 10.1177/1751143719840259

Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer Reporting

Louis DN, Wesseling P, Brandner S, Brat DJ, Ellison DW, Giangaspero F, Hattab EM, Hawkins C, Judge MJ, Kleinschmidt-DeMasters B, Komori T, McLean C, Paulus W, Perry A, Reifenberger G, Weller M, Rous B

(2020), Arch Pathol Lab Med, 144(2), 196-206

DOI: 10.5858/arpa.2018-0565-OA

Neurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivo

Jeon MT, Moon GJ, Kim S, Choi M, Oh YS, Kim DW, Kim HJ, Lee KJ, Choe Y, Ha CM, Jang IS, Nakamura M, McLean C, Chung WS, Shin WH, Lee SG, Kim SR

(2020), BRIT J PHARMACOL, 177(3), 668-86

DOI: 10.1111/bph.14882

Acral lentiginous melanoma: differences in survival compared with other subtypes.

Howard MD, Xie C, Wee E, Wolfe R, McLean CA, Kelly JW, Pan Y

(2020), Brit J Dermatol, 182(4), 1056-7

DOI: 10.1111/bjd.18620

Characterising the brain metalloproteome in Down syndrome patients with concomitant Alzheimer's pathology

Malakooti N , Roberts B , Pritchard MA , Volitakis I , Kim RC , Lott IT , McLean CA , Finkelstein DI , Adlard PA

(2020), Metallomics, 12(1), 114-32

DOI: 10.1039/c9mt00196d

Regional iron distribution and soluble ferroprotein profiles in the healthy human brain

McAllum EJ, Hare DJ, Volitakis I, McLean CA, Bush AI, Finkelstein DI, Roberts BR

(2020), Prog Neurobiol, 186, 101744

DOI: 10.1016/j.pneurobio.2019.101744

The anatomic distribution of cutaneous melanoma: A detailed study of 5141 lesions

Wee E, Wolfe R, Mclean C, Kelly JW, Pan Y

(2020), Australas J Dermatol, 61(2), 125-33

DOI: 10.1111/ajd.13223

Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabine

Prabahran A, Tacey M, Fleming S, Wei A, Tate C, Marlton P, Wight J, Grigg A, Tuckfield A, Szer J, Ritchie D, Chee L

(2020), Eur J Haematol,

Severity of mucositis during allogeneic transplantation impacts post-transplant cyclosporin absorption

Tan JLC, Wong E, Bajel A, Ramanan R, Lim ABM, Ritchie DS

(2020), BONE MARROW TRANSPL, 55(9), 1857-9

DOI: 10.1038/s41409-020-0795-7

LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations

Brar N, Butzmann A, Kumar J, Peerani R, Morgan EA, Grigoriadis G, Kumar B, Tatarczuch RM, Warnke RA, Ohgami RS

(2020), Histopathology, 77(6), 984-88

DOI: 10.1111/his.14176

Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells

Teh CE, Gong JN, Segal D, Tan T, Vandenberg CJ, Fedele PL, Low MSY, Grigoriadis G, Harrison SJ, Strasser A, Roberts AW, Huang DCS, Nolan GP, Gray DHD, Ko ME

(2020), Cell Death Differ, 27(7), 2217-33

DOI: 10.1038/s41418-020-0498-z

Quality audit of the guidelines for the use of RhD immunoglobulin in obstetrics: Are we getting it right?

Glazebrook B, Akers C, Bielby L, Bastin K, Von Wielligh K, Daly J

(2020), AUST NZ J OBSTET GYN, 60(4), 504-8

DOI: 10.1111/ajo.13177

Treatment practice and outcomes in FLT3-mutant acute myeloid leukemia in the pre-midostaurin era: a real-world experience from Australian tertiary hospitals

Chua CC, Grigg A, Singh J, Droogleever MP, Zhang L, Lim A, Fong CY, Ting SB, Schwarer A, Tiong IS, Wei AH

(2020), LEUKEMIA LYMPHOMA, 61(4), 848-54

DOI: 10.1080/10428194.2019.1691192

3 4 5 6 7